These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 31569090)

  • 1. Effectiveness and Safety of Combination Therapy of Transarterial Chemoembolization and Apatinib for Unresectable Hepatocellular Carcinoma in the Chinese Population: A Meta-Analysis.
    Wei Y; Liu J; Yan M; Zhao S; Long Y; Zhang W
    Chemotherapy; 2019; 64(2):94-104. PubMed ID: 31569090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of transarterial chemoembolization plus sorafenib for early or intermediate stage hepatocellular carcinoma: A systematic review and meta-analysis of randomized controlled trials.
    Zeng J; Lv L; Mei ZC
    Clin Res Hepatol Gastroenterol; 2016 Dec; 40(6):688-697. PubMed ID: 27339594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of transarterial chemoembolization combined with targeted therapy and immunotherapy versus with targeted monotherapy in unresectable hepatocellular carcinoma: A systematic review and meta-analysis.
    Feng J; Zhao Y; Zhai L; Zhou J
    Medicine (Baltimore); 2024 May; 103(18):e38037. PubMed ID: 38701263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis.
    Tian X; Dai Y; Wang DQ; Zhang L; Sui CG; Meng FD; Jiang SY; Liu YP; Jiang YH
    Drug Des Devel Ther; 2015; 9():4431-40. PubMed ID: 26309396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long-term efficacy and safety of apatinib are inferior to sorafenib in the first-line treatment of advanced hepatocellular carcinoma: A systematic review and meta-analysis.
    Li D; Zhang C; Yang K; Ma Z; Ma L; Cheng C; Xu L; Wan S
    Medicine (Baltimore); 2024 Jan; 103(3):e36865. PubMed ID: 38241568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of efficacy between TACE combined with apatinib and TACE alone in the treatment of intermediate and advanced hepatocellular carcinoma: A single-center randomized controlled trial.
    Lu W; Jin XL; Yang C; Du P; Jiang FQ; Ma JP; Yang J; Xie P; Zhang Z
    Cancer Biol Ther; 2017 Jun; 18(6):433-438. PubMed ID: 28548587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and safety of Apatinib combined with TACE in the treatment of hepatocellular carcinoma: a meta-analysis.
    Gong A; Li X
    World J Surg Oncol; 2022 Mar; 20(1):69. PubMed ID: 35246145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of transcatheter arterial chemoembolization used with and without apatinib for intermediate- to advanced-stage hepatocellular carcinoma: a systematic review and meta-analysis.
    Zhao S; Zhang T; Dou W; Wang E; Wang M; Wang C; Du X; Liu L
    Ann Transl Med; 2020 Apr; 8(8):542. PubMed ID: 32411765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transarterial chemoembolization plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review and meta-analysis.
    Li L; Zhao W; Wang M; Hu J; Wang E; Zhao Y; Liu L
    BMC Gastroenterol; 2018 Sep; 18(1):138. PubMed ID: 30180810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety and efficacy of TACE combined with apatinib on patients with advanced hepatocellular carcinoma: a retrospective study.
    Yang Z; Chen G; Cui Y; Xiao G; Su T; Yu J; Zhang Z; Han Y; Yang K; Jin L
    Cancer Biol Ther; 2019; 20(3):321-327. PubMed ID: 30332553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalidomide combined with transcatheter artierial chemoembolzation for primary hepatocellular carcinoma: a systematic review and meta-analysis.
    Cao DD; Xu HL; Liu L; Zheng YF; Gao SF; Xu XM; Ge W
    Oncotarget; 2017 Jul; 8(27):44976-44993. PubMed ID: 28402958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of transcatheter arterial chemoembolization combined with ginsenosides in hepatocellular carcinoma treatment.
    Zhu H; Wang SY; Zhu JH; Liu H; Kong M; Mao Q; Zhang W; Li SL
    Phytomedicine; 2021 Oct; 91():153700. PubMed ID: 34425474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy and safety of Transarterial chemoembolization with and without Apatinib for the treatment of BCLC stage C hepatocellular carcinoma.
    Chen S; Yu W; Zhang K; Liu W
    BMC Cancer; 2018 Nov; 18(1):1131. PubMed ID: 30453925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic trioxide combined with transarterial chemoembolization for unresectable primary hepatic carcinoma: A systematic review and meta-analysis.
    Song P; Hai Y; Ma W; Zhao L; Wang X; Xie Q; Li Y; Wu Z; Li Y; Li H
    Medicine (Baltimore); 2018 May; 97(18):e0613. PubMed ID: 29718867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late combination of transarterial chemoembolization with apatinib and camrelizumab for unresectable hepatocellular carcinoma is superior to early combination.
    Ju S; Zhou C; Hu J; Wang Y; Wang C; Liu J; Yang C; Huang S; Li T; Chen Y; Bai Y; Yao W; Xiong B
    BMC Cancer; 2022 Mar; 22(1):335. PubMed ID: 35346114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of the efficacy and safety of iodine [
    Fan W; Wu Y; Lu M; Yao W; Cui W; Zhao Y; Wang Y; Li J
    Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):451-459. PubMed ID: 30348520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of transarterial chemoembolization plus lenvatinib combined with PD-1 inhibitors versus transarterial chemoembolization plus lenvatinib for unresectable hepatocellular carcinoma: a meta-analysis.
    Chen Y; Jia L; Li Y; Cui W; Wang J; Zhang C; Bian C; Luo T
    Front Immunol; 2024; 15():1466113. PubMed ID: 39281676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of drug-eluting bead transarterial chemoembolization (DEB-TACE) combined with tyrosine kinase inhibitors (TKIs) in patients with unresectable hepatocellular carcinoma (uHCC): A systematic review and meta-analysis.
    Ji J; Zhang Z; Hou Z; Qiu G; Mi S; Jin Z; Huang J
    Clin Res Hepatol Gastroenterol; 2024 Apr; 48(4):102313. PubMed ID: 38453011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of efficacy and safety of the transcatheter arterial chemoembolization with or without apatinib in the treatment of large hepatocellular carcinoma.
    Liu J; Xie S; Duan X; Chen J; Zhou X; Li Y; Li Z; Han X
    Cancer Chemother Pharmacol; 2020 Jan; 85(1):69-76. PubMed ID: 31813003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of Survival Rate for Patients with Hepatocellular Carcinoma Using Transarterial Chemoembolization in Combination with Three-Dimensional Conformal Radiation Therapy: A Meta-Analysis.
    Bai H; Gao P; Gao H; Sun G; Dong C; Han J; Jiang G
    Med Sci Monit; 2016 May; 22():1773-81. PubMed ID: 27228411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.